on Biophytis (EPA:ALBPS)
Biophytis to Attend 2025 JP Morgan Healthcare Conference in San Francisco
Biophytis, a biotechnology company focused on age-related diseases, will attend the 2025 JP Morgan Healthcare Conference in San Francisco. The event, scheduled from January 13-16, is the largest global gathering in the healthcare sector, convening industry leaders and investors worldwide.
In addition, Biophytis will participate in the BioPharma Obesity Innovation Forum on January 11. This inaugural forum will address obesity treatment challenges and advancements, gathering over 100 companies and investors. Biophytis plans to present its strategic positioning and key milestones in obesity treatment.
Furthermore, Biophytis will engage with potential pharmaceutical partners and investors at the BIO@JPM Week Conference. These events provide a platform for Biophytis to discuss their development programs and future plans.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biophytis news